Impact of biological therapy in reducing the risk of arthritis development in inflammatory bowel diseases
Objective Evaluate spondyloarthritis (SpA) incidence in inflammatory bowel diseases (IBD) between patients treated with biological disease-modifying antirheumatic drugs (bDMARDs) and conventional DMARDs (cDMARDs) and define risk factors associated with SpA development.Methods Retrospective cohort st...
Saved in:
| Main Authors: | Paola Conigliaro, Maria Sole Chimenti, Paola Triggianese, Alberto Bergamini, Mauro Fatica, Benedetta Monosi, Arianna D’Antonio, Sara Essofi, Elisa Cuccagna, Livia Biancone, Giovanni Monteleone, Emma Calabrese |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-02-01
|
| Series: | RMD Open |
| Online Access: | https://rmdopen.bmj.com/content/10/1/e003820.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risankizumab Efficacy in Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Remission: A Case Report on Rheumatologic and Dermatologic Disease Manifestations with Literature Review
by: Mario Ferraioli, et al.
Published: (2024-01-01) -
Validation of “Clinical Red Flags” for RA-ILD in an Italian cohort
by: Eneida Cela, et al.
Published: (2025-07-01) -
Upadacitinib for the treatment of radiographic axial spondyloarthritis — case series and review of the literature
by: Giuseppe Lopalco, et al.
Published: (2025-05-01) -
Alteration of telomere length and mtDNA copy number in interstitial lung disease associated with rheumatoid arthritis
by: Giada De Benedittis, et al.
Published: (2025-12-01) -
Downregulation of immunoglobulin-like transcript-4 (ILT4) in patients with psoriatic arthritis.
by: Alberto Bergamini, et al.
Published: (2014-01-01)